Kristensen DM, Lesn L, Le Fol V, et al
Trial: Dapiglutide, a dual GLP-1 and GLP-2 receptor agonist, for obesity: a randomised, double-blind, placebo-controlled parallel-group, proof-of-concept trial
They can choose a higher-cost plan for their employees that includes GLP-1 coverage, or choose to save money by dropping the coverage
On the basis of the current limited data, although there is large heterogeneity in the dose of 10 mg in lowering FBG in Asians, the difference in efficacy between Asians and non-Asians is undeniable
Our physicians tailor a gradual tapering strategy while also adjusting your nutrition plan, and helping establish long-term lifestyle habits that support lasting weight maintenance
Many patients report that a small amount of dessert or sweet drink no longer triggers the intense sugar high and crash cycle they once experienced